Several studies suggest that FOXO3 protein acts as a tumor suppressor in breast cancer by inducing the expression of cyclin-dependent kinase inhibitors (CDK inhibitors) and proapoptotic proteins16,35. This evidence concerns the gene FOXO3 and breast carcinoma.